1.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00164, MC0513, U01CA069912, CDR0000476275, MAYO-MC0513, 7380, NCI-7380, MAYO-IAB-05-00404800, MAYO-IAB-05-00404801, NCT00348699
|